Shionogi to End Sale of Aimix, Sumitomo to Continue

October 4, 2022
Shionogi is discontinuing the sale of Aimix (irbesartan + amlodipine), a hypertension drug being comarketed with Sumitomo Pharma. It plans to end its shipments in mid-December for “various reasons,” the company said in a notice to healthcare providers. Sumitomo, which...read more